Amarin reported $-69956000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
DBV Technologies DBVT:US -23039000 6.33M
Abbvie ABBV:US $ 924M 3566M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Amarin AMRN:US $ -69.96M 38.39M
AstraZeneca AZN:LN 29568.96M 177.38M
Biocryst Pharmaceuticals BCRX:US $ -58.86M 15.34M
Epizyme EPZM:US $ -35.74M 19.76M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
GlaxoSmithKline GSK:LN 83800M 96400M
Halozyme Therapeutics HALO:US $ 22.68M 37.42M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Novartis NOVN:VX SF 1694M 528M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M